FDA Panel Recommends Split Classifications For Cardiac Devices
This article was originally published in The Gray Sheet
Executive Summary
Circulatory System Devices panel recommends either class II or class III designations for external counter-pulsating devices and intra-aortic balloon pumps, depending on the indication.
You may also be interested in...
Class Act: Status Of CDRH’s 515 Initiative
Chart updating FDA’s progress and decisions in classifying the final set of preamendment devices.
Regulatory News In Brief
Agency issues proposed orders to reclassify intra-aortic balloon and control systems, tuberculosis IVDs and stair-climbing wheelchairs. Industry mainly supports FDA’s communications draft guidance. More regulatory news.
Abiomed’s Impella Cardiac Pump Needs PMA Study, FDA Panel Says
Better data is needed in the form of a PMA study to assess the safety and effectiveness of Abiomed’s flagship Impella 2.5 blood pump, advisory panel recommends.